NYSE$HLIO
Helios Technologies Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Helios Technologies reported strong revenue growth in Q1 2023 while investing in augmented strategy for future growth.
Helios Technologies reported strong top-line results and delivered on gross margins in Q1 2023. The company is investing in optimizing its long-term cost structure and preparing for global growth, including opening new Centers of Excellence and reorganizing the Hydraulics segment. They also announced an agreement to acquire i3 Product Development.
- Strong sequential top line growth over 4Q22 in both segments including a 36% increase in the health and wellness end market and sequential consolidated margin growth
- Investing in operating expenses (SEA) to integrate flywheel acquisitions, open previously announced Centers of Excellence, and accelerate strategic growth opportunities
- Protecting full year margin and earnings through execution of manufacturing and operating strategy
- Achieved diluted EPS of $0.42; Diluted Non-GAAP Cash EPS of $0.72 reflecting in-period investments, higher interest expense ($0.06), and FX impact ($0.04) compared with prior year
Headline financials
Revenue & EPS history
Helios · Revenue · Quarterly
$213M
Revenue by segment
Helios · $213M total across 2 segments · Q1 2023
- Hydraulics$148M—69.3%
- Electronics$65.5M—30.7%
Forward guidance
The company reiterates its outlook for 2023 revenue to be $910 to $940 million and is on path to achieve a strategic milestone of $1 billion in revenue on a run rate basis by year-end 2023. On a run-rate basis ending 2023, the Company expects to reach approximately $1 billion in revenue and approximately 25% Adjusted EBITDA margins.
Tailwinds
- Reiterating outlook for 2023 revenue expected to be $910 to $940 million
- On path to achieve strategic milestone of $1 billion in revenue on a run rate basis by year-end 2023
- Expecting to reach approximately $1 billion in revenue on a run-rate basis ending 2023
- Expecting approximately 25% Adjusted EBITDA margins on a run-rate basis ending 2023
- Combined with our organic growth and other recent acquisitions, we expect to be able to reach our $1 billion revenue milestone with top-tier margins on a run-rate basis ending 2023
Headwinds
- Foreign currency translation adjustment on sales was $3.5 million unfavorable
- Supply chain constraints delayed an estimated $12.4 million in sales in the quarter
- Rising interest rates
- Average net debt balance increases related to acquisitions
- The ongoing, though improving contraction of the health and wellness end market
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2023
+1.1%
Avg return
Earnings day
+1.5%
Avg return
5 days after
+0.9%
Avg return
30 days after
59%
37 / 63 earnings
Positive
+20.9%
Q3 2016
Best reaction
-23.8%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.0% | +2.5% | +17.3% | |
| Q4 2025 | -3.8% | -12.6% | -9.6% | |
| Q3 2025 | -1.6% | -4.0% | -4.3% | |
| Q1 2025 | +6.5% | +21.0% | +19.2% | |
| Q4 2024 | +7.1% | +1.6% | -12.3% | |
| Q3 2024 | +14.9% | +7.8% | +7.2% | |
| Q2 2024 | +5.4% | +4.2% | -0.8% | |
| Q1 2024 | +6.8% | +5.7% | -2.5% | |
| Q4 2023 | +7.3% | -0.4% | -2.2% | |
| Q3 2023 | -13.7% | -16.7% | -21.9% | |
| Q2 2023 | -12.4% | -7.3% | -7.0% | |
| Q1 2023 | -7.6% | -12.2% | -2.0% | |
| Q4 2022 | +2.6% | +9.6% | -1.9% | |
| Q3 2022 | -10.8% | -5.1% | -6.0% | |
| Q2 2022 | -12.1% | +0.5% | -19.5% | |
| Q1 2022 | -4.4% | -1.7% | +5.6% | |
| Q4 2021 | -4.4% | -4.2% | +2.0% | |
| Q3 2021 | +16.0% | +15.2% | +8.0% | |
| Q2 2021 | +4.0% | +2.3% | +3.5% | |
| Q1 2021 | -0.2% | +3.6% | -3.7% | |
| Q3 2020 | +7.0% | +5.8% | +17.3% | |
| Q2 2020 | +4.6% | +11.6% | +12.8% | |
| Q1 2020 | +2.2% | +2.4% | +9.4% | |
| Q4 2019 | -0.2% | -4.9% | -15.2% | |
| Q3 2019 | +11.4% | +7.2% | +4.4% | |
| Q2 2019 | +2.2% | -3.2% | -5.9% | |
| Q1 2019 | -9.7% | -9.9% | -10.7% | |
| Q4 2018 | +20.8% | +27.9% | +16.7% | |
| Q3 2018 | -23.8% | -17.1% | -18.9% | |
| Q2 2018 | -4.3% | -8.0% | -2.5% | |
| Q1 2018 | -0.2% | -0.8% | +4.5% | |
| Q4 2017 | -5.1% | -6.4% | -5.8% | |
| Q3 2017 | -1.9% | -0.3% | -1.7% | |
| Q2 2017 | +13.9% | +12.3% | +21.6% | |
| Q1 2017 | +5.9% | +5.0% | +5.4% | |
| Q4 2016 | -4.8% | -8.8% | -7.4% | |
| Q3 2016 | +20.9% | +32.8% | +34.4% | |
| Q2 2016 | +1.6% | +0.6% | +6.6% | |
| Q1 2016 | -10.9% | — | — | |
| Q4 2015 | +7.3% | — | — | |
| Q3 2015 | +0.1% | — | — | |
| Q2 2015 | -3.7% | — | — | |
| Q1 2015 | -4.9% | — | — | |
| Q4 2014 | +2.4% | — | — | |
| Q3 2014 | +6.7% | — | — | |
| Q2 2014 | +4.8% | — | — | |
| Q1 2014 | -6.4% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | +3.8% | — | — | |
| Q2 2013 | +0.6% | — | — | |
| Q1 2013 | -1.3% | — | — | |
| Q4 2011 | +2.3% | — | — | |
| Q4 2012 | +12.5% | — | — | |
| Q3 2012 | +1.6% | — | — | |
| Q2 2012 | +0.1% | — | — | |
| Q1 2012 | +2.1% | — | — | |
| Q4 2010 | +1.3% | — | — | |
| Q3 2011 | -3.1% | — | — | |
| Q2 2011 | +3.2% | — | — | |
| Q1 2011 | +3.2% | — | — | |
| Q3 2010 | -1.8% | — | — | |
| Q2 2010 | -9.6% | — | — | |
| Q1 2010 | +15.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro